MedTrace Logo

High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer

NCT00988130 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: High-intensity focused ultrasound focal ablation uses high-energy sound waves to kill tumor cells.

PURPOSE: This phase II trial is studying the side effects of high-intensity focused ultrasound focal ablation and to see how well it works in treating patients with progressive prostate cancer.

Conditions

Interventions

OTHER

laboratory biomarker analysis

OTHER

questionnaire administration

PROCEDURE

assessment of therapy complications

PROCEDURE

high-intensity focused ultrasound ablation

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • University College London Hospitals

    lead OTHER

Principal Investigators

  • Mark Emberton, MD, FRCS, MBBS · University College London Hospitals

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00988130 on ClinicalTrials.gov